Relationship between human platelet antigen-1 gene polymorphism and clopidogrel resistance in patients with coronary artery disease
Yükleniyor...
Dosyalar
Tarih
2013
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Turkish Soc Cardiology
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Objectives: It has been proposed that human platelet antigen-1 (HPA-1) gene polymorphism is associated with coronary artery disease (CAD) and affects platelet function. We aimed to investigate the distribution of HPA gene polymorphism between angiographic CAD and a control group and the relation between HPA gene polymorphism and platelet aggregation. Study design: The study population consisted of 94 patients with angiographic CAD and 115 patients without angiographic CAD. Platelet aggregation was measured with impedance aggregometry on the fifth day of percutaneous coronary intervention (PCI). Platelet aggregation >480 AU/min was defined as the clopidogrel resistance. Blood samples were obtained from all participants at discharge for the analysis of HPA-1 gene polymorphism. Results: There was no significant difference in the distribution of HPA-1 gene polymorphism between the control and CAD groups (78.7% vs. 78.1% for A allele and 21.3% vs. 21.9% for B allele, p=NS). The analysis between groups with and without clopidogrel resistance revealed no significant difference in the distribution of HPA-1A and HPA-1B alleles between the groups (A allele 78.7% vs. 78.9% and B allele 21.3% vs. 21.1%, p=NS). In the CAD group, there were no significant differences in platelet aggregation between HPA-1A and HPA-1B alleles (294 +/- 240 vs. 259 +/- 261 AU/min, p=NS). Conclusion: Distribution of HPA-1 gene polymorphism was not different in CAD patients compared to the control group. HPA-1 gene polymorphism was not associated with platelet aggregation or clopidogrel resistance assessed by impedance aggregometry in the CAD group.
Açıklama
Anahtar Kelimeler
Angioplasty, balloon, coronary/methods, dose-response relationship, drug, drug resistance, human platelet antigen-1, clopidogrel, percutaneous coronary intervention, polymorphism, genetic, platelet aggregation/drug effects/genetics
Kaynak
Turk Kardiyoloji Dernegi Arsivi-Archives of The Turkish Society of Cardiology
WoS Q Değeri
N/A
Scopus Q Değeri
Q3
Cilt
41
Sayı
5
